25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Chengdu Easton Biopharmaceuticals Co Ltd
Buy, Hold or Sell?

Let's analyze Chengdu Easton Biopharmaceuticals Co Ltd together

I guess you are interested in Chengdu Easton Biopharmaceuticals Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chengdu Easton Biopharmaceuticals Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Chengdu Easton Biopharmaceuticals Co Ltd

I send you an email if I find something interesting about Chengdu Easton Biopharmaceuticals Co Ltd.

1. Quick Overview

1.1. Quick analysis of Chengdu Easton Biopharmaceuticals Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Chengdu Easton Biopharmaceuticals Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
73.9%

What is your share worth?

Current worth
¥15.16
Expected worth in 1 year
¥15.76
How sure are you?
87.0%

+ What do you gain per year?

Total Gains per Share
¥1.02
Return On Investment
3.3%

For what price can you sell your share?

Current Price per Share
¥30.70
Expected price per share
¥28.85 - ¥32.07
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Chengdu Easton Biopharmaceuticals Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥30.70
Intrinsic Value Per Share
¥-2.20 - ¥-2.43
Total Value Per Share
¥12.96 - ¥12.74

2.2. Growth of Chengdu Easton Biopharmaceuticals Co Ltd (5 min.)




Is Chengdu Easton Biopharmaceuticals Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$367.5m$344.3m$18.6m5.1%

How much money is Chengdu Easton Biopharmaceuticals Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$8.5m$8.4m$176.3k2.1%
Net Profit Margin18.8%21.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Chengdu Easton Biopharmaceuticals Co Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Chengdu Easton Biopharmaceuticals Co Ltd?

Welcome investor! Chengdu Easton Biopharmaceuticals Co Ltd's management wants to use your money to grow the business. In return you get a share of Chengdu Easton Biopharmaceuticals Co Ltd.

First you should know what it really means to hold a share of Chengdu Easton Biopharmaceuticals Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Chengdu Easton Biopharmaceuticals Co Ltd is ¥30.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chengdu Easton Biopharmaceuticals Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chengdu Easton Biopharmaceuticals Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥15.16. Based on the TTM, the Book Value Change Per Share is ¥0.15 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.25 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chengdu Easton Biopharmaceuticals Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.050.2%0.050.2%0.050.2%0.040.1%0.040.1%
Usd Book Value Change Per Share0.010.0%0.020.1%0.030.1%0.100.3%0.090.3%
Usd Dividend Per Share0.020.1%0.010.0%0.010.0%0.010.0%0.010.0%
Usd Total Gains Per Share0.030.1%0.030.1%0.050.2%0.110.4%0.100.3%
Usd Price Per Share5.54-7.27-7.69-5.97-5.19-
Price to Earnings Ratio25.27-43.91-41.15-34.57-30.06-
Price-to-Total Gains Ratio175.59-261.67-161.94-169.39-169.39-
Price to Book Ratio2.66-3.54-3.95-3.22-2.80-
Price-to-Total Gains Ratio175.59-261.67-161.94-169.39-169.39-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.21511
Number of shares237
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.020.10
Usd Total Gains Per Share0.030.11
Gains per Quarter (237 shares)8.2927.23
Gains per Year (237 shares)33.15108.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1141923109999
227395620197208
341588931296317
4557812241395426
5699715551493535
68211718861592644
79613622172691753
811015525482790862
912417528792888971
101371943201029871080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%23.00.00.0100.0%23.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%19.01.00.095.0%19.01.03.082.6%19.01.03.082.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%17.00.03.085.0%17.00.06.073.9%17.00.06.073.9%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%20.00.03.087.0%20.00.03.087.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Chengdu Easton Biopharmaceuticals Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0560.149-62%0.252-78%0.758-93%0.659-91%
Book Value Per Share--15.16414.974+1%14.206+7%12.146+25%10.562+44%
Current Ratio--2.9282.822+4%3.202-9%3.351-13%2.914+1%
Debt To Asset Ratio--0.2170.225-4%0.192+13%0.204+6%0.177+22%
Debt To Equity Ratio--0.2770.291-5%0.238+16%0.259+7%0.225+23%
Dividend Per Share--0.1740.105+65%0.100+73%0.079+121%0.068+154%
Enterprise Value--6387170249.0308572127494.368-25%9629621793.080-34%9330782178.902-32%9330782178.902-32%
Eps--0.4000.354+13%0.347+15%0.316+27%0.298+34%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--4.3116.808-37%8.598-50%8.400-49%8.400-49%
Free Cash Flow Per Share--0.2230.156+43%-0.012+106%-0.103+146%-0.072+132%
Free Cash Flow To Equity Per Share--0.2230.156+43%-0.030+113%0.248-10%0.229-3%
Gross Profit Margin--1.0001.0000%0.469+113%-0.641+164%-0.776+178%
Intrinsic Value_10Y_max---2.425--------
Intrinsic Value_10Y_min---2.200--------
Intrinsic Value_1Y_max---0.475--------
Intrinsic Value_1Y_min---0.467--------
Intrinsic Value_3Y_max---1.251--------
Intrinsic Value_3Y_min---1.198--------
Intrinsic Value_5Y_max---1.814--------
Intrinsic Value_5Y_min---1.699--------
Market Cap5419532400.000-32%7128374274.0009342093729.308-24%9889335307.800-28%7675704452.102-7%6674525610.523+7%
Net Profit Margin--0.1900.188+1%0.218-13%0.200-5%0.1910%
Operating Margin----0%0.046-100%0.052-100%0.045-100%
Operating Ratio--1.0431.049-1%0.939+11%0.808+29%0.743+40%
Pb Ratio2.024-32%2.6633.541-25%3.947-33%3.218-17%2.798-5%
Pe Ratio19.210-32%25.26743.913-42%41.149-39%34.566-27%30.058-16%
Price Per Share30.700-32%40.38052.920-24%56.020-28%43.481-7%37.809+7%
Price To Free Cash Flow Ratio34.432-32%45.2896.801+566%15.670+189%-17.057+138%-14.832+133%
Price To Total Gains Ratio133.494-32%175.586261.671-33%161.942+8%169.391+4%169.391+4%
Quick Ratio--1.5961.384+15%2.198-27%3.437-54%2.989-47%
Return On Assets--0.0210.018+13%0.020+5%0.022-6%0.019+8%
Return On Equity--0.0260.024+12%0.024+8%0.028-5%0.024+9%
Total Gains Per Share--0.2300.255-10%0.352-35%0.837-73%0.728-68%
Usd Book Value--367553393.141362939271.092+1%344332285.452+7%294392726.111+25%255993674.879+44%
Usd Book Value Change Per Share--0.0080.020-62%0.035-78%0.104-93%0.091-91%
Usd Book Value Per Share--2.0822.056+1%1.951+7%1.668+25%1.450+44%
Usd Dividend Per Share--0.0240.014+65%0.014+73%0.011+121%0.009+154%
Usd Enterprise Value--876958475.1921176953104.977-25%1322147072.190-34%1281116393.163-32%1281116393.163-32%
Usd Eps--0.0550.049+13%0.048+15%0.043+27%0.041+34%
Usd Free Cash Flow--5402724.3533774275.630+43%-300370.540+106%-2490346.022+146%-1741875.378+132%
Usd Free Cash Flow Per Share--0.0310.021+43%-0.002+106%-0.014+146%-0.010+132%
Usd Free Cash Flow To Equity Per Share--0.0310.021+43%-0.004+113%0.034-10%0.031-3%
Usd Market Cap744101798.520-32%978725787.8201282669469.034-24%1357805737.761-28%1053874221.274-7%916412366.325+7%
Usd Price Per Share4.215-32%5.5447.266-24%7.692-28%5.970-7%5.191+7%
Usd Profit--9683939.9458577195.544+13%8400852.263+15%7650290.135+27%7219113.436+34%
Usd Revenue--50859141.47544872311.832+13%38536778.732+32%38042105.946+34%37128666.174+37%
Usd Total Gains Per Share--0.0320.035-10%0.048-35%0.115-73%0.100-68%
 EOD+4 -4MRQTTM+25 -12YOY+21 -185Y+17 -2210Y+22 -17

3.3 Fundamental Score

Let's check the fundamental score of Chengdu Easton Biopharmaceuticals Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.210
Price to Book Ratio (EOD)Between0-12.024
Net Profit Margin (MRQ)Greater than00.190
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.596
Current Ratio (MRQ)Greater than12.928
Debt to Asset Ratio (MRQ)Less than10.217
Debt to Equity Ratio (MRQ)Less than10.277
Return on Equity (MRQ)Greater than0.150.026
Return on Assets (MRQ)Greater than0.050.021
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Chengdu Easton Biopharmaceuticals Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose30.410
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Chengdu Easton Biopharmaceuticals Co Ltd

Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry, and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.

Fundamental data was last updated by Penke on 2025-02-15 01:12:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Chengdu Easton Biopharmaceuticals Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Chengdu Easton Biopharmaceuticals Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of 19.0% means that ¥0.19 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 19.0%. The company is making a huge profit. +2
  • The TTM is 18.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ19.0%TTM18.8%+0.2%
TTM18.8%YOY21.8%-3.0%
TTM18.8%5Y20.0%-1.1%
5Y20.0%10Y19.1%+0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.0%-101.0%+120.0%
TTM18.8%-203.6%+222.4%
YOY21.8%-199.0%+220.8%
5Y20.0%-333.8%+353.8%
10Y19.1%-481.5%+500.6%
4.3.1.2. Return on Assets

Shows how efficient Chengdu Easton Biopharmaceuticals Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chengdu Easton Biopharmaceuticals Co Ltd to the Biotechnology industry mean.
  • 2.1% Return on Assets means that Chengdu Easton Biopharmaceuticals Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 2.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.1%TTM1.8%+0.2%
TTM1.8%YOY2.0%-0.1%
TTM1.8%5Y2.2%-0.4%
5Y2.2%10Y1.9%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%-12.4%+14.5%
TTM1.8%-12.4%+14.2%
YOY2.0%-11.8%+13.8%
5Y2.2%-13.2%+15.4%
10Y1.9%-15.2%+17.1%
4.3.1.3. Return on Equity

Shows how efficient Chengdu Easton Biopharmaceuticals Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chengdu Easton Biopharmaceuticals Co Ltd to the Biotechnology industry mean.
  • 2.6% Return on Equity means Chengdu Easton Biopharmaceuticals Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 2.6%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.4%+0.3%
TTM2.4%YOY2.4%-0.1%
TTM2.4%5Y2.8%-0.4%
5Y2.8%10Y2.4%+0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6%-15.9%+18.5%
TTM2.4%-16.6%+19.0%
YOY2.4%-15.2%+17.6%
5Y2.8%-19.0%+21.8%
10Y2.4%-20.5%+22.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Chengdu Easton Biopharmaceuticals Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Chengdu Easton Biopharmaceuticals Co Ltd is operating .

  • Measures how much profit Chengdu Easton Biopharmaceuticals Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chengdu Easton Biopharmaceuticals Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY4.6%-4.6%
TTM-5Y5.2%-5.2%
5Y5.2%10Y4.5%+0.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM--316.3%+316.3%
YOY4.6%-208.2%+212.8%
5Y5.2%-367.6%+372.8%
10Y4.5%-483.9%+488.4%
4.3.2.2. Operating Ratio

Measures how efficient Chengdu Easton Biopharmaceuticals Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.04 means that the operating costs are ¥1.04 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 1.043. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.049. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.043TTM1.049-0.006
TTM1.049YOY0.939+0.109
TTM1.0495Y0.808+0.241
5Y0.80810Y0.743+0.065
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0432.167-1.124
TTM1.0493.118-2.069
YOY0.9393.194-2.255
5Y0.8084.689-3.881
10Y0.7436.422-5.679
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Chengdu Easton Biopharmaceuticals Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Chengdu Easton Biopharmaceuticals Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.93 means the company has ¥2.93 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 2.928. The company is able to pay all its short-term debts. +1
  • The TTM is 2.822. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.928TTM2.822+0.106
TTM2.822YOY3.202-0.380
TTM2.8225Y3.351-0.528
5Y3.35110Y2.914+0.437
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9283.586-0.658
TTM2.8223.854-1.032
YOY3.2024.496-1.294
5Y3.3515.971-2.620
10Y2.9146.269-3.355
4.4.3.2. Quick Ratio

Measures if Chengdu Easton Biopharmaceuticals Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chengdu Easton Biopharmaceuticals Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.60 means the company can pay off ¥1.60 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 1.596. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.384. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.596TTM1.384+0.212
TTM1.384YOY2.198-0.814
TTM1.3845Y3.437-2.054
5Y3.43710Y2.989+0.448
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5963.068-1.472
TTM1.3843.312-1.928
YOY2.1984.393-2.195
5Y3.4375.972-2.535
10Y2.9896.490-3.501
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Chengdu Easton Biopharmaceuticals Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Chengdu Easton Biopharmaceuticals Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chengdu Easton Biopharmaceuticals Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.22 means that Chengdu Easton Biopharmaceuticals Co Ltd assets are financed with 21.7% credit (debt) and the remaining percentage (100% - 21.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 0.217. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.225. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.217TTM0.225-0.009
TTM0.225YOY0.192+0.033
TTM0.2255Y0.204+0.022
5Y0.20410Y0.177+0.027
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2170.340-0.123
TTM0.2250.341-0.116
YOY0.1920.310-0.118
5Y0.2040.363-0.159
10Y0.1770.384-0.207
4.5.4.2. Debt to Equity Ratio

Measures if Chengdu Easton Biopharmaceuticals Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chengdu Easton Biopharmaceuticals Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.7% means that company has ¥0.28 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The MRQ is 0.277. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.291. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.277TTM0.291-0.014
TTM0.291YOY0.238+0.053
TTM0.2915Y0.259+0.033
5Y0.25910Y0.225+0.034
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2770.387-0.110
TTM0.2910.428-0.137
YOY0.2380.391-0.153
5Y0.2590.451-0.192
10Y0.2250.495-0.270
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Chengdu Easton Biopharmaceuticals Co Ltd generates.

  • Above 15 is considered overpriced but always compare Chengdu Easton Biopharmaceuticals Co Ltd to the Biotechnology industry mean.
  • A PE ratio of 25.27 means the investor is paying ¥25.27 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The EOD is 19.210. Based on the earnings, the company is fair priced.
  • The MRQ is 25.267. Based on the earnings, the company is overpriced. -1
  • The TTM is 43.913. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD19.210MRQ25.267-6.057
MRQ25.267TTM43.913-18.646
TTM43.913YOY41.149+2.764
TTM43.9135Y34.566+9.347
5Y34.56610Y30.058+4.509
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD19.210-2.221+21.431
MRQ25.267-2.782+28.049
TTM43.913-3.254+47.167
YOY41.149-3.403+44.552
5Y34.566-6.225+40.791
10Y30.058-6.819+36.877
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The EOD is 34.432. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 45.289. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 6.801. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD34.432MRQ45.289-10.857
MRQ45.289TTM6.801+38.487
TTM6.801YOY15.670-8.868
TTM6.8015Y-17.057+23.858
5Y-17.05710Y-14.832-2.225
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD34.432-3.007+37.439
MRQ45.289-3.693+48.982
TTM6.801-3.891+10.692
YOY15.670-4.438+20.108
5Y-17.057-8.306-8.751
10Y-14.832-9.274-5.558
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Chengdu Easton Biopharmaceuticals Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.66 means the investor is paying ¥2.66 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Chengdu Easton Biopharmaceuticals Co Ltd:

  • The EOD is 2.024. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.663. Based on the equity, the company is underpriced. +1
  • The TTM is 3.541. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.024MRQ2.663-0.638
MRQ2.663TTM3.541-0.878
TTM3.541YOY3.947-0.406
TTM3.5415Y3.218+0.323
5Y3.21810Y2.798+0.420
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.0241.910+0.114
MRQ2.6632.190+0.473
TTM3.5412.397+1.144
YOY3.9472.465+1.482
5Y3.2183.815-0.597
10Y2.7984.512-1.714
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,418,213
Total Liabilities741,204
Total Stockholder Equity2,677,009
 As reported
Total Liabilities 741,204
Total Stockholder Equity+ 2,677,009
Total Assets = 3,418,213

Assets

Total Assets3,418,213
Total Current Assets1,940,299
Long-term Assets1,477,914
Total Current Assets
Cash And Cash Equivalents 585,013
Short-term Investments 824,184
Net Receivables 233,040
Inventory 184,328
Other Current Assets 5,207
Total Current Assets  (as reported)1,940,299
Total Current Assets  (calculated)1,831,773
+/- 108,527
Long-term Assets
Property Plant Equipment 1,255,525
Intangible Assets 101,598
Long-term Assets Other 24,398
Long-term Assets  (as reported)1,477,914
Long-term Assets  (calculated)1,381,521
+/- 96,393

Liabilities & Shareholders' Equity

Total Current Liabilities662,572
Long-term Liabilities78,632
Total Stockholder Equity2,677,009
Total Current Liabilities
Short Long Term Debt 125,892
Accounts payable 163,734
Other Current Liabilities 13,546
Total Current Liabilities  (as reported)662,572
Total Current Liabilities  (calculated)303,172
+/- 359,401
Long-term Liabilities
Long term Debt 38,160
Long-term Liabilities  (as reported)78,632
Long-term Liabilities  (calculated)38,160
+/- 40,471
Total Stockholder Equity
Retained Earnings 1,126,955
Total Stockholder Equity (as reported)2,677,009
Total Stockholder Equity (calculated)1,126,955
+/- 1,550,055
Other
Capital Stock176,532
Common Stock Shares Outstanding 176,532
Net Invested Capital 2,841,061
Net Working Capital 1,277,727
Property Plant and Equipment Gross 1,255,525



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
987,081
965,022
1,100,043
2,408,514
2,530,857
2,556,133
2,580,557
2,740,284
2,775,266
2,861,799
2,903,209
3,003,472
3,017,540
3,098,766
3,085,438
3,215,971
3,346,754
3,374,371
3,514,139
3,418,213
3,418,2133,514,1393,374,3713,346,7543,215,9713,085,4383,098,7663,017,5403,003,4722,903,2092,861,7992,775,2662,740,2842,580,5572,556,1332,530,8572,408,5141,100,043965,022987,081000
   > Total Current Assets 
0
0
0
631,294
0
641,206
1,842,594
1,893,943
1,852,529
1,811,056
1,851,731
1,779,070
1,689,144
1,617,194
1,664,529
1,709,122
1,742,813
1,700,289
1,786,564
1,882,871
1,903,687
2,039,771
1,940,299
1,940,2992,039,7711,903,6871,882,8711,786,5641,700,2891,742,8131,709,1221,664,5291,617,1941,689,1441,779,0701,851,7311,811,0561,852,5291,893,9431,842,594641,2060631,294000
       Cash And Cash Equivalents 
0
0
0
404,057
0
400,805
1,412,759
1,055,289
211,431
292,037
210,384
1,050,695
596,831
435,267
559,858
830,967
620,514
640,574
535,353
781,231
823,669
682,618
585,013
585,013682,618823,669781,231535,353640,574620,514830,967559,858435,267596,8311,050,695210,384292,037211,4311,055,2891,412,759400,8050404,057000
       Short-term Investments 
0
0
0
0
0
0
170,000
570,000
1,411,500
1,254,840
1,374,461
453,841
815,344
879,194
766,077
516,364
740,648
727,134
880,464
741,782
663,972
851,135
824,184
824,184851,135663,972741,782880,464727,134740,648516,364766,077879,194815,344453,8411,374,4611,254,8401,411,500570,000170,000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
94,449
100,930
137,554
136,941
137,128
111,857
142,102
120,179
161,361
221,495
233,040
233,040221,495161,361120,179142,102111,857137,128136,941137,554100,93094,449000000000000
       Other Current Assets 
0
0
0
166,824
0
166,454
178,322
184,625
141,636
174,387
177,035
170,850
24,105
19,689
21,158
22,842
25,061
5,243
6,303
11,731
8,901
11,127
5,207
5,20711,1278,90111,7316,3035,24325,06122,84221,15819,68924,105170,850177,035174,387141,636184,625178,322166,4540166,824000
   > Long-term Assets 
0
0
0
355,788
965,022
458,837
565,920
636,914
703,604
769,501
888,553
996,197
1,172,655
1,286,015
1,338,943
1,308,418
1,355,952
1,385,149
1,429,407
1,463,883
1,470,684
1,474,369
1,477,914
1,477,9141,474,3691,470,6841,463,8831,429,4071,385,1491,355,9521,308,4181,338,9431,286,0151,172,655996,197888,553769,501703,604636,914565,920458,837965,022355,788000
       Property Plant Equipment 
0
0
0
301,085
0
391,767
488,556
571,679
633,487
696,955
808,927
874,595
973,523
1,008,466
1,099,572
1,140,970
1,163,523
1,191,260
1,216,654
1,254,968
1,255,933
1,249,821
1,255,525
1,255,5251,249,8211,255,9331,254,9681,216,6541,191,2601,163,5231,140,9701,099,5721,008,466973,523874,595808,927696,955633,487571,679488,556391,7670301,085000
       Intangible Assets 
0
0
0
35,227
0
34,719
34,464
34,219
34,051
33,799
33,611
41,757
50,462
59,535
68,995
77,008
78,575
79,776
80,298
84,456
93,220
97,193
101,598
101,59897,19393,22084,45680,29879,77678,57577,00868,99559,53550,46241,75733,61133,79934,05134,21934,46434,719035,227000
> Total Liabilities 
0
0
0
289,638
236,707
316,019
362,750
435,610
417,233
403,196
493,882
483,602
515,961
569,714
609,934
573,081
592,973
575,825
644,306
743,334
748,261
847,066
741,204
741,204847,066748,261743,334644,306575,825592,973573,081609,934569,714515,961483,602493,882403,196417,233435,610362,750316,019236,707289,638000
   > Total Current Liabilities 
0
0
0
277,116
0
295,420
343,714
385,275
367,685
351,649
441,311
432,459
464,865
520,958
563,973
529,387
546,134
533,772
557,768
661,094
666,672
767,529
662,572
662,572767,529666,672661,094557,768533,772546,134529,387563,973520,958464,865432,459441,311351,649367,685385,275343,714295,4200277,116000
       Short-term Debt 
0
0
0
4,695
0
40,000
40,000
40,028
40,028
0
0
20,023
50,050
120,344
141,011
105,293
0
0
0
0
0
0
0
0000000105,293141,011120,34450,05020,0230040,02840,02840,00040,00004,695000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
50,050
120,344
141,011
105,293
124,650
131,078
131,100
180,948
161,087
210,321
125,892
125,892210,321161,087180,948131,100131,078124,650105,293141,011120,34450,050000000000000
       Accounts payable 
0
0
0
51,175
0
64,531
84,903
122,732
142,917
155,836
221,875
203,916
209,420
182,140
173,217
156,859
166,155
169,358
157,160
180,938
174,899
188,478
163,734
163,734188,478174,899180,938157,160169,358166,155156,859173,217182,140209,420203,916221,875155,836142,917122,73284,90364,531051,175000
       Other Current Liabilities 
0
0
0
206,476
0
169,499
199,752
204,805
172,718
179,774
197,403
208,520
205,395
218,474
249,744
267,236
5,690
2,561
4,127
2,515
8,253
4,639
13,546
13,5464,6398,2532,5154,1272,5615,690267,236249,744218,474205,395208,520197,403179,774172,718204,805199,752169,4990206,476000
   > Long-term Liabilities 
0
0
0
12,521
236,707
20,599
19,036
50,335
49,549
51,546
52,571
51,143
51,096
48,757
45,961
43,693
46,839
42,053
86,537
82,240
81,589
79,537
78,632
78,63279,53781,58982,24086,53742,05346,83943,69345,96148,75751,09651,14352,57151,54649,54950,33519,03620,599236,70712,521000
> Total Stockholder Equity
0
0
0
697,444
728,315
784,024
2,045,764
2,095,247
2,138,899
2,177,362
2,246,402
2,291,665
2,345,838
2,333,494
2,393,538
2,444,460
2,505,792
2,509,613
2,571,666
2,603,420
2,626,110
2,667,074
2,677,009
2,677,0092,667,0742,626,1102,603,4202,571,6662,509,6132,505,7922,444,4602,393,5382,333,4942,345,8382,291,6652,246,4022,177,3622,138,8992,095,2472,045,764784,024728,315697,444000
   Common Stock
0
0
0
90,000
0
90,000
120,090
120,090
120,090
120,090
120,090
120,090
120,090
120,090
120,090
120,090
0
0
0
0
0
0
0
0000000120,090120,090120,090120,090120,090120,090120,090120,090120,090120,09090,000090,000000
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
283,596
728,315
284,099
1,476,964
1,489,506
1,489,866
1,490,304
1,490,612
1,504,166
1,504,537
1,505,030
1,504,217
1,504,111
0
0
0
0
0
0
0
00000001,504,1111,504,2171,505,0301,504,5371,504,1661,490,6121,490,3041,489,8661,489,5061,476,964284,099728,315283,596000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,117,121
Cost of Revenue-223,274
Gross Profit893,847893,847
 
Operating Income (+$)
Gross Profit893,847
Operating Expense-909,908
Operating Income207,213-16,061
 
Operating Expense (+$)
Research Development238,491
Selling General Administrative344,187
Selling And Marketing Expenses0
Operating Expense909,908582,677
 
Net Interest Income (+$)
Interest Income14,696
Interest Expense-3,418
Other Finance Cost-126
Net Interest Income11,152
 
Pretax Income (+$)
Operating Income207,213
Net Interest Income11,152
Other Non-Operating Income Expenses0
Income Before Tax (EBT)241,640207,213
EBIT - interestExpense = -3,418
226,574
229,992
Interest Expense3,418
Earnings Before Interest and Taxes (EBIT)0245,058
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax241,640
Tax Provision-15,065
Net Income From Continuing Ops226,574226,574
Net Income226,574
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-11,152
 

Technical Analysis of Chengdu Easton Biopharmaceuticals Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chengdu Easton Biopharmaceuticals Co Ltd. The general trend of Chengdu Easton Biopharmaceuticals Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chengdu Easton Biopharmaceuticals Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chengdu Easton Biopharmaceuticals Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 31.68 < 31.76 < 32.07.

The bearish price targets are: 29.96 > 29.92 > 28.85.

Tweet this
Chengdu Easton Biopharmaceuticals Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chengdu Easton Biopharmaceuticals Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chengdu Easton Biopharmaceuticals Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chengdu Easton Biopharmaceuticals Co Ltd. The current adx is .

Chengdu Easton Biopharmaceuticals Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Relative Strength Index (RSI) ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Stochastic Oscillator ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Commodity Channel Index (CCI) ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Chande Momentum Oscillator (CMO) ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Williams %R ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Average True Range (ATR) ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily On-Balance Volume (OBV) ChartChengdu Easton Biopharmaceuticals Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chengdu Easton Biopharmaceuticals Co Ltd.

Chengdu Easton Biopharmaceuticals Co Ltd Daily Money Flow Index (MFI) ChartChengdu Easton Biopharmaceuticals Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chengdu Easton Biopharmaceuticals Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-23BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Chengdu Easton Biopharmaceuticals Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chengdu Easton Biopharmaceuticals Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose30.410
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Chengdu Easton Biopharmaceuticals Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Chengdu Easton Biopharmaceuticals Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chengdu Easton Biopharmaceuticals Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chengdu Easton Biopharmaceuticals Co Ltd

I send you an email if I find something interesting about Chengdu Easton Biopharmaceuticals Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Chengdu Easton Biopharmaceuticals Co Ltd.

Receive notifications about Chengdu Easton Biopharmaceuticals Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.